Status:
COMPLETED
Effects of Hand MOtor Rehabilitation Using a sEMG-biofeedback
Lead Sponsor:
IRCCS San Camillo, Venezia, Italy
Conditions:
Stroke
Stroke, Ischemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stroke is the first cause of disability worldwide. The motor impairment of the hand is one of the most common sequelae in patients after stroke. Indeed, approximately 60% of patients with diagnosis of...
Detailed Description
The aim of the study is to investigate the effect of using REMO® (Morecognition srl, Turin, Italy) device in hand motor rehabilitation. The device REMO® is an armband composed by 8 bipolar electrodes...
Eligibility Criteria
Inclusion
- Single ischemic or haemorrhagic stroke
- able to control at least 1 movement with REMO (i.e. able to cross the pre-defined empirical threshold (10%) of the ratio between the maximum voluntary contraction (MVC) of the movement and the EMG recording during baseline (i.e. rest position)
Exclusion
- Untreated epilepsy;
- Major depressive disorder;
- Fractures;
- Traumatic Brain Injury;
- Severe Ideomotor Apraxia;
- Severe Neglect;
- Severe impairment of verbal comprehension.
Key Trial Info
Start Date :
August 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05416619
Start Date
August 14 2017
End Date
February 27 2019
Last Update
June 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Camillo Hospital
Venice-Lido, Venice, Italy, 30126